Chidiogo Nwokike, NP
Nurse Practitioner · Las Vegas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 8 years
- Graduated 2018
Offices
1 location
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Chidiogo Nwokike’s office at (702) 778-7782 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$8,466
Medicare paid this office $8,466 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 12 | $5,643 | $79 |
| Psychotherapy with evaluation and management visit, 30 minutes | 12 | $2,501 | $46 |
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 63 · Health risk score 1.17. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: Depression 75%.
The office billed $29,160, Medicare allowed $11,010 and paid $8,466; for 130 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 12 | 130 | 63 | 1.17 | $29,160 | $8,466 |
| 2023 | 18 | 194 | 62 | 1.42 | $25,581 | $12,862 |
| 2022 | 30 | 169 | 59 | 1.71 | $21,184 | $11,093 |
| 2021 | 24 | 153 | 58 | 1.05 | $18,412 | $8,512 |
| 2020 | 25 | 126 | 64 | 2.59 | $11,951 | $6,350 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 16 | $7,237 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 17 | $3,668 | $45 |
2022: 3 services
| Return visit (30+ min) | 17 | $5,546 | $85 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $3,588 | $48 |
| New patient visit (45+ min) | 13 | $1,419 | $109 |
2021: 3 services
| Return visit (30+ min) | 17 | $3,039 | $80 |
| Short return visit (20+ min) | 16 | $2,354 | $60 |
| Telehealth originating site facility fee | 14 | $865 | $21 |
2020: 1 service
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 16 | $4,774 | $48 |
Medicaid work
$28,917 in 2024
Medicaid paid $28,917 for 521 billed services this clinician did in 2024, up to 37 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 291 | $19,191 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 196 | $6,590 |
| Clinic visit/encounter, all-inclusive | 18 | $2,417 |
| Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 16 | $719 |
| 2024 | 521 | 4 | 37 | $28,917 |
| 2023 | 732 | 4 | 41 | $30,663 |
| 2022 | 944 | 3 | 61 | $39,490 |
| 2021 | 808 | 3 | 62 | $32,837 |
| 2020 | 267 | 3 | 19 | $7,159 |
| 2019 | 48 | 1 | 14 | $2,148 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 338 | $17,791 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 307 | $9,209 |
| Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 74 | $3,198 |
| Short return visit (20+ min) | 13 | $465 |
2022
| Return visit (30+ min) | 303 | $16,490 |
| Short return visit (20+ min) | 295 | $12,026 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 346 | $10,974 |
2021
| Short return visit (20+ min) | 545 | $20,732 |
| Return visit (30+ min) | 164 | $9,745 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 99 | $2,360 |
2020
| Return visit (30+ min) | 76 | $3,101 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 119 | $2,388 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 72 | $1,670 |
2019
| Return visit (30+ min) | 48 | $2,148 |
Drugs they prescribed that Part D paid
$36,509
Pharmacies billed $36,509 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 441) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
412 generic and 29 brand-name prescriptions · $36,509 in drug cost · 23 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trintellix | 13 | $6,130 | $472 |
| Aripiprazole | 20 | $1,934 | $97 |
| Trazodone | 52 | $983 | $19 |
| Olanzapine | 11 | $477 | $43 |
| Mirtazapine | 28 | $464 | $17 |
See all 16 drugs
| Trintellix | 13 | $6,130 | $472 |
| Aripiprazole | 20 | $1,934 | $97 |
| Trazodone | 52 | $983 | $19 |
| Olanzapine | 11 | $477 | $43 |
| Mirtazapine | 28 | $464 | $17 |
| Duloxetine | 34 | $365 | $11 |
| Buspirone | 18 | $239 | $13 |
| Alprazolam | 43 | $205 | $5 |
| Fluvoxamine Maleate | 11 | $162 | $15 |
| Quetiapine | 13 | $158 | $12 |
| Lamotrigine | 24 | $129 | $5 |
| Sertraline | 24 | $111 | $5 |
| Fluoxetine | 19 | $83 | $4 |
| Escitalopram | 18 | $64 | $4 |
| Lorazepam | 14 | $45 | $3 |
| Clonazepam | 24 | $40 | $2 |
Year by year
| 2024 | 441 | 39 | 0% (0) | 7% | $36,509 |
| 2023 | 364 | 38 | 0% (0) | 9% | $37,316 |
| 2022 | 396 | 45 | 0% (0) | 3% | $20,861 |
| 2021 | 485 | 49 | 0% (0) | None | $24,784 |
| 2020 | 387 | 85 | 0% (0) | 9% | $33,675 |
| 2019 | 1,023 | 117 | 0% (0) | 9% | $115,310 |
| 2018 | 117 | 35 | 0% (0) | None | $4,233 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Rexulti | 12 | $18,729 | $1,561 |
| Trazodone | 40 | $1,561 | $39 |
| Duloxetine | 29 | $934 | $32 |
| Mirtazapine | 37 | $661 | $18 |
| Gabapentin | 12 | $255 | $21 |
| Escitalopram | 19 | $219 | $12 |
| Buspirone | 27 | $211 | $8 |
| Alprazolam | 24 | $68 | $3 |
| Quetiapine | 16 | $53 | $3 |
| Clonazepam | 15 | $50 | $3 |
| Lamotrigine | 12 | $46 | $4 |
| Fluoxetine | 12 | $33 | $3 |
2022: 15 drugs
| Aripiprazole | 25 | $840 | $34 |
| Escitalopram | 40 | $625 | $16 |
| Gabapentin | 13 | $590 | $45 |
| Mirtazapine | 28 | $505 | $18 |
| Duloxetine | 20 | $368 | $18 |
| Trazodone | 15 | $353 | $24 |
| Bupropion Hcl Sr | 11 | $350 | $32 |
| Sertraline | 36 | $340 | $9 |
| Clonazepam | 18 | $339 | $19 |
| Olanzapine | 18 | $335 | $19 |
| Quetiapine | 24 | $265 | $11 |
| Hydroxyzine | 13 | $242 | $19 |
| Alprazolam | 28 | $150 | $5 |
| Lamotrigine | 16 | $123 | $8 |
| Risperidone | 12 | $87 | $7 |
2021: 18 drugs
| Dextroamphetamine-Amphet Er | 17 | $1,480 | $87 |
| Aripiprazole | 12 | $1,209 | $101 |
| Ziprasidone | 17 | $1,113 | $65 |
| Trazodone | 29 | $847 | $29 |
| Duloxetine | 36 | $842 | $23 |
| Olanzapine | 20 | $593 | $30 |
| Buspirone | 18 | $566 | $31 |
| Divalproex Sodium Er | 13 | $472 | $36 |
| Gabapentin | 11 | $379 | $34 |
| Quetiapine | 23 | $359 | $16 |
| Sertraline | 19 | $328 | $17 |
| Risperidone | 39 | $307 | $8 |
| Lamotrigine | 30 | $302 | $10 |
| Clonazepam | 22 | $243 | $11 |
| Mirtazapine | 20 | $219 | $11 |
| Alprazolam | 23 | $212 | $9 |
| Escitalopram | 23 | $194 | $8 |
| Fluoxetine | 15 | $94 | $6 |
2020: 16 drugs
| Rexulti | 11 | $12,060 | $1,096 |
| Dextroamphetamine-Amphet Er | 13 | $1,572 | $121 |
| Duloxetine | 15 | $761 | $51 |
| Buspirone | 19 | $511 | $27 |
| Dextroamphetamine-Amphetamine | 15 | $443 | $30 |
| Divalproex | 11 | $403 | $37 |
| Olanzapine | 11 | $375 | $34 |
| Alprazolam | 15 | $293 | $20 |
| Risperidone | 28 | $273 | $10 |
| Sertraline | 24 | $262 | $11 |
| Quetiapine | 14 | $236 | $17 |
| Trazodone | 23 | $207 | $9 |
| Bupropion Hcl Sr | 11 | $168 | $15 |
| Fluoxetine | 19 | $142 | $7 |
| Hydroxyzine Pamoate | 13 | $128 | $10 |
| Clonazepam | 20 | $76 | $4 |
2019: 27 drugs
| Rexulti | 23 | $27,088 | $1,178 |
| Latuda | 16 | $26,727 | $1,670 |
| Saphris | 14 | $15,737 | $1,124 |
| Divalproex Sodium Er | 25 | $1,657 | $66 |
| Aripiprazole | 35 | $1,338 | $38 |
| Trazodone | 87 | $1,033 | $12 |
| Quetiapine | 67 | $1,018 | $15 |
| Risperidone | 68 | $1,003 | $15 |
| Duloxetine | 27 | $968 | $36 |
| Bupropion Xl | 36 | $725 | $20 |
| Divalproex | 30 | $667 | $22 |
| Buspirone | 38 | $521 | $14 |
| Escitalopram | 38 | $518 | $14 |
| Bupropion Hcl Sr | 18 | $508 | $28 |
| Sertraline | 67 | $474 | $7 |
| Ziprasidone | 14 | $442 | $32 |
| Fluoxetine | 53 | $442 | $8 |
| Alprazolam | 60 | $441 | $7 |
| Mirtazapine | 25 | $368 | $15 |
| Hydroxyzine Pamoate | 25 | $362 | $14 |
| Clonazepam | 23 | $243 | $11 |
| Lorazepam | 34 | $235 | $7 |
| Topiramate | 20 | $198 | $10 |
| Benztropine Mesylate | 12 | $155 | $13 |
| Zolpidem | 14 | $153 | $11 |
| Lamotrigine | 15 | $140 | $9 |
| Citalopram Hbr | 17 | $76 | $4 |
2018: 3 drugs
| Quetiapine | 13 | $144 | $11 |
| Sertraline | 20 | $104 | $5 |
| Alprazolam | 11 | $98 | $9 |
Money from drug and device companies
$68 in 2025
| 2025 | 1 | 3 | None | $68 |
| 2024 | 2 | 2 | None | $28 |
| 2023 | 1 | 1 | None | $112 |
| 2022 | 3 | 10 | None | $289 |
| 2021 | 7 | 32 | None | $499 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $68 | 3 payments
|
See all 3 published payments
| Abbvie | Meals · 2025-10-14 | Vraylar | $25 |
| Abbvie | Meals · 2025-05-15 | Vraylar | $19 |
| Abbvie | Meals · 2025-04-25 | Vraylar | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $28
| Ironshore Pharmaceuticals | Jornay Pm | $19 | 1 payment
|
| Corium | Azstarys | $8 | 1 payment
|
2023: $112
| Teva Pharmaceuticals USA | Austedo Xr | $112 | 1 payment
|
2022: $289
| Iti | Caplyta | $141 | 3 payments
|
| Abbvie | Vraylar | $126 | 6 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $22 | 1 payment
|
2021: $499
| Supernus Pharmaceuticals | Qelbree | $130 | 9 payments
|
| AbbVie | Vraylar | $112 | 7 payments
|
| Iti | Caplyta | $82 | 5 payments
|
| Sunovion Pharmaceuticals | Latuda | $65 | 6 payments
|
| Avanir Pharmaceuticals | Nuedexta | $48 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $39 | 2 payments
|
| Eisai | Dayvigo | $24 | 1 payment
|
Professional record
- NPI
- 1184114522
- Licence
- CA 95014548, NV APRN002910
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 10141 Rockridge Peak Ave, Las Vegas, NV, 89166
- NPI first listed
- 2018-05-11
- NPI last updated
- 2023-02-13
- NPI record certified
- 2023-02-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1340 Tully Rd Ste 301&304, San Jose, CA, 95122